Skip to content

GRAIL, Inc. GRAL Additional Paid-In Capital

Additional Paid-In Capital at other companies

Guardant Health logo
Guardant HealthGH
$2.93B+18.5%
Natera, Inc. logo
Natera, Inc.NTRA
$4.64B+19.6%
Tempus AI, Inc. logo
Tempus AI, Inc.TEM
$2.95B+15.8%
Immunome logo
ImmunomeIMNM
$1.37B+58.5%
Adaptive Biotechnologies logo
Adaptive BiotechnologiesADPT
$1.6B+5.0%
Erasca, Inc. logo
Erasca, Inc.ERAS
$1.47B+22.7%

Other financials

Income statement

See full
Revenue$40.8M+28.1%
Operating income-$135.8M+11.6%
Net income-$93.2M+12.3%
EPS (diluted)-$2.29+26.1%

Balance sheet

See full
Cash & equivalents$76.3M-44.4%
Total debt$51.0M-20.7%
Total equity$2.5B+3.6%
Total assets$2.8B-1.5%

Cash flow

See full
Operating cash flow-$87.0M+8.4%
CapEx$503.0K+711%
Free cash flow-$87.5M+8.0%

Valuation

See full
Market cap$2.62B+145%
Enterprise value$2.6B+164%
P/S16.8×+8.6×

Profitability

See full
Operating margin-348.7%-153pp
Net margin-253.2%-115pp
FCF margin-187.2%-60.4pp

Returns & leverage

See full
Return on equity-16.1%
Debt / equity0.0×
Current ratio11.7×+2.0×

Where this comes from

Reported directly by GRAIL, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AdditionalPaidInCapital.

The official record: GRAIL, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about GRAIL, Inc.'s additional paid-in capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is GRAIL, Inc.'s additional paid-in capital?
GRAIL, Inc. (GRAL) reported additional paid-in capital of $12.8B in Q1 2026.
How has GRAIL, Inc.'s additional paid-in capital changed year-over-year?
GRAIL, Inc.'s additional paid-in capital increased by 3.9% year-over-year, from $12.32B to $12.8B.
What does additional paid-in capital mean?
Capital received from shareholders in excess of par value — the premium investors paid over the nominal value of shares at issuance, plus stock-based compensation effects.